Article Information
History
- March 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Kathleen M. Andersen, PhD MSc1,*,
- Leah J. McGrath, PhD1,
- Maya Reimbaeva, MS1,
- Diana Mendes, PhD2,
- Jennifer L. Nguyen, ScD MPH MHCI1,
- Kiran K. Rai, PhD3,
- Theo Tritton, MSc3,
- Carmen Tsang, PhD2,
- Deepa Malhotra, MS1 and
- Jingyan Yang, DrPH MHS1,4
- 1Pfizer Inc, New York, NY 10001
- 2Pfizer Ltd, Tadworth, UK
- 3Adelphi Real World, Bollington, UK
- 4Institute for Social and Economic Research and Policy, Columbia University, New York, NY 10027
- ↵*Corresponding Author:
Kathleen M. Andersen, PhD, Senior Manager, Vaccines Real World Evidence Pfizer Inc., New York, NY Phone: 443-540-9961, Email: kathleen.andersen{at}pfizer.com